Medicrea International SA Revenue Q/Q
What is the Revenue Q/Q of Medicrea International SA?
The Revenue Q/Q of Medicrea International SA is -30.42%
What is the definition of Revenue Q/Q?
Quarterly revenue growth, year over year, is the increase of a company’s revenue compared to the performance in the corresponding quarter of a previous year expressed as a percentage.
quarterly growth yoy (year over year)
Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.
Revenue Q/Q of companies in the Health Care sector on LSE compared to Medicrea International SA
What does Medicrea International SA do?
Medicrea International SA designs, manufactures, and distributes spinal implants in France and internationally. It offers PASS range, a polyaxial spine system; PASS LP, a thoraco-lumbar fixation system; LigaPASS, a band connector for posterior thoracolumbar fixation; PASS TULIP, a top loading posterior fixation system; PASS DEGEN for thoracic and lumbar degenerative indications; PASS OCT, an occipito-cervico-thoracic fixation system; PASS MIS, a posterior anchoring system; PASS Antérieur that offers a range of specific implants enabling surgery using an anterior approach; IMPIX C, a sterile PEEK Optima cervical interbody device; IMPIX-C+, a sterile PEEK Optima cervical interbody device that is prefilled with bone substitute; and IMPIX-MANTA, a sterile PEEK Optima cervical interbody device that is preassembled on holder/ impactor and delivers with a disposable instrumentation kit. Its implants for cervical spine also include IMPIX-MANTA +, a sterile PEEK Optima cervical interbody device, which is prefilled with synthetic bone substitutes; and GRANVIA-C, a MRI compatible ceramic cervical disc. In addition, it provides implants for the thoracic and lumbar spine, such as IMPIX-L, a sterile PEEK Optima lumbar interbody device for posterior approach; IMPIX-TLIF, a sterile PEEK Optima lumbar interbody device for transforaminal approach with a pre-assembled PEEK control lead; IMPIX-ALIF, a sterile PEEK Optima lumbar interbody device for anterior approach; STABOLT, an anatomically-shaped anterior plate; OSMOSYS, a macroporous bone substitute; IMPIX-DLIF and IMPIX-DLIF SLIM sterile PEEK Optima lumbar interbody devices for direct or oblique lateral approach; and X-JAWS, a titanium lumbar staple to secure a lateral or an anterior cage. Its implants are designed to treat scoliosis, degenerative diseases, malformations, trauma, and tumors; and used in various traditional and surgical procedures. The company was founded in 1990 and is headquartered in Rillieux-la-Pape, France.
Companies with revenue q/q similar to Medicrea International SA
- Clover Health Investments Corp has Revenue Q/Q of -30.64%
- PeerStream has Revenue Q/Q of -30.63%
- Garrison Capital has Revenue Q/Q of -30.48%
- The Select Sector SPDR Trust - The Consumer Discretionary Select Sector SPDR Fund has Revenue Q/Q of -30.47%
- Andersons has Revenue Q/Q of -30.47%
- Tailam Tech Constr Hldg Ltd has Revenue Q/Q of -30.44%
- Medicrea International SA has Revenue Q/Q of -30.42%
- Capitala Finance Corp has Revenue Q/Q of -30.36%
- Zeotech has Revenue Q/Q of -30.34%
- Bbtv Inc has Revenue Q/Q of -30.33%
- Hind Rectifiers has Revenue Q/Q of -30.33%
- Atlantia SpA has Revenue Q/Q of -30.32%
- Glory Mark Hi-Tech () has Revenue Q/Q of -30.32%